The Pat Kenny Show cover image

Public cancer patients being denied new drugs

The Pat Kenny Show

00:00

Deciding Which Drugs Merit Access

Pat asks about cost‑benefit thresholds; Dr. McCarthy discusses quality‑adjusted life year thresholds and clinical effectiveness considerations.

Play episode from 10:15
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app